Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump administration buffets global trade with tariffs.
Categories:
Related Post
McKinstry grows bigger in Texas
Headquartered in Seattle, the integrated services provider said economic growth and the data center boom…
Climate change will cost your healthcare plan. Analysts want to know how much.
Extreme weather, rising temperatures and increased air pollution all threaten employee health — but executives…
Flatiron/AECOM JV ordered to pay AECOM subsidiary $14.2M
The ruling follows a multiyear battle between the contractors’ joint venture and AECOM Technical Services,…